Aperam S.A.
APEMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,831 | $2,374 | $2,219 | $3,804 |
| - Cash | $216 | $443 | $457 | $524 |
| + Debt | $760 | $934 | $925 | $990 |
| Enterprise Value | $2,375 | $2,865 | $2,687 | $4,270 |
| Revenue | $6,255 | $6,592 | $8,156 | $5,102 |
| % Growth | -5.1% | -19.2% | 59.9% | – |
| Gross Profit | $449 | $330 | $1,180 | $1,233 |
| % Margin | 7.2% | 5% | 14.5% | 24.2% |
| EBITDA | $354 | $364 | $958 | $1,197 |
| % Margin | 5.7% | 5.5% | 11.7% | 23.5% |
| Net Income | $231 | $203 | $625 | $968 |
| % Margin | 3.7% | 3.1% | 7.7% | 19% |
| EPS Diluted | 3.17 | 2.79 | 8.29 | 12.17 |
| % Growth | 13.6% | -66.3% | -31.9% | – |
| Operating Cash Flow | $280 | $471 | $642 | $550 |
| Capital Expenditures | -$155 | -$301 | -$296 | -$152 |
| Free Cash Flow | $125 | $170 | $346 | $398 |